In the BioHarmony Drug Report Database
Methylthioninium chloride
Provayblue (methylene blue) is a small molecule pharmaceutical. Methylene blue was first approved as Provayblue on 2016-04-08. It is used to treat cyanosis, herpes simplex, lithiasis, methemoglobinemia, and poisoning amongst others in the USA.
Trade Name
|
Provayblue |
|---|---|
Common Name
|
methylene blue |
ChEMBL ID
|
CHEMBL550495 |
Indication
|
cyanosis, herpes simplex, lithiasis, methemoglobinemia, poisoning, urinary tract infections |
Drug Class
|
Image (chem structure or protein)